(Q35666095)

9 August 2017

1 reference

title

Spotlight on vardenafil in erectile dysfunction (English)

1 reference

9 August 2017

2

Lesley J Scott

1 reference

9 August 2017

1

Gillian M Keating

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

21

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

135-140

1 reference

Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.

9 August 2017

cites work

1 reference

12 December 2020

Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction

1 reference

12 December 2020

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

12 December 2020

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

1 reference

12 December 2020

Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

1 reference

12 December 2020

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

1 reference

12 December 2020

The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.

1 reference

12 December 2020

The oral efficacy of vardenafil hydrochloride for inducing penile erection in a conscious rabbit model

1 reference

12 December 2020

A conscious-rabbit model to study vardenafil hydrochloride and other agents that influence penile erection

1 reference

12 December 2020

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

1 reference

12 December 2020

10.2165/00002512-200421020-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1042054008

0 references

1 reference